GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (BSP:T1EV34) » Definitions » E10

Teva Pharmaceutical Industries (BSP:T1EV34) E10 : R$-5.93 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Teva Pharmaceutical Industries E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Teva Pharmaceutical Industries's adjusted earnings per share data for the three months ended in Dec. 2023 was R$2.009. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is R$-5.93 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was -31.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Teva Pharmaceutical Industries was 31.70% per year. The lowest was -105.40% per year. And the median was 16.10% per year.

As of today (2024-04-30), Teva Pharmaceutical Industries's current stock price is R$35.37. Teva Pharmaceutical Industries's E10 for the quarter that ended in Dec. 2023 was R$-5.93. Teva Pharmaceutical Industries's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Teva Pharmaceutical Industries was 288.58. The lowest was 6.57. And the median was 22.29.


Teva Pharmaceutical Industries E10 Historical Data

The historical data trend for Teva Pharmaceutical Industries's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teva Pharmaceutical Industries E10 Chart

Teva Pharmaceutical Industries Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -3.21 -4.55 -5.58 -5.93

Teva Pharmaceutical Industries Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.58 -6.09 -5.45 -4.69 -5.93

Competitive Comparison of Teva Pharmaceutical Industries's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Teva Pharmaceutical Industries's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Teva Pharmaceutical Industries's Shiller PE Ratio falls into.



Teva Pharmaceutical Industries E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Teva Pharmaceutical Industries's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2.009/129.4194*129.4194
=2.009

Current CPI (Dec. 2023) = 129.4194.

Teva Pharmaceutical Industries Quarterly Data

per share eps CPI Adj_EPS
201403 2.023 99.695 2.626
201406 1.945 100.560 2.503
201409 2.385 100.428 3.074
201412 2.114 99.070 2.762
201503 1.634 99.621 2.123
201506 1.960 100.684 2.519
201509 0.468 100.392 0.603
201512 2.134 99.792 2.768
201603 2.293 100.470 2.954
201606 0.685 101.688 0.872
201609 1.139 101.861 1.447
201612 -3.723 101.863 -4.730
201703 1.783 102.862 2.243
201706 -19.575 103.349 -24.513
201709 1.629 104.136 2.025
201712 -37.596 104.011 -46.780
201803 3.377 105.290 4.151
201806 -0.905 106.317 -1.102
201809 -1.109 106.507 -1.348
201812 -11.068 105.998 -13.514
201903 -0.384 107.251 -0.463
201906 -2.429 108.070 -2.909
201909 -1.195 108.329 -1.428
201912 0.410 108.420 0.489
202003 0.293 108.902 0.348
202006 0.674 108.767 0.802
202009 -21.438 109.815 -25.265
202012 0.720 109.897 0.848
202103 0.394 111.754 0.456
202106 0.955 114.631 1.078
202109 1.373 115.734 1.535
202112 -0.792 117.630 -0.871
202203 -4.280 121.301 -4.566
202206 -1.060 125.017 -1.097
202209 0.262 125.227 0.271
202212 -5.770 125.222 -5.963
202303 -0.938 127.348 -0.953
202306 -3.737 128.729 -3.757
202309 0.346 129.860 0.345
202312 2.009 129.419 2.009

Add all the adjusted EPS together and divide 10 will get our e10.


Teva Pharmaceutical Industries  (BSP:T1EV34) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Teva Pharmaceutical Industries was 288.58. The lowest was 6.57. And the median was 22.29.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Teva Pharmaceutical Industries E10 Related Terms

Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Teva Pharmaceutical Industries (BSP:T1EV34) Business Description

Address
124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the U.S. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a U.S.-based generic and specialty drug distributor.

Teva Pharmaceutical Industries (BSP:T1EV34) Headlines

No Headlines